Basetrophy GP maintains stable share structure in October 2026 monthly return

Bulletin Express11-02

Basetrophy Group Holdings Limited (Basetrophy GP) reported no changes to its share capital structure for the month ended 31 October 2026, according to its latest filing with Hong Kong Exchanges and Clearing Limited dated 2 November 2026.

Key highlights:

• Authorised share capital remained at 3.00 billion ordinary shares with a par value of HKD 0.10 each, equivalent to HKD 300.00 million.

• Issued share capital was unchanged at 265.61 million ordinary shares, while treasury shares stayed at zero; consequently, total issued shares also stood at 265.61 million.

• The company confirmed compliance with the minimum 25% public-float requirement under GEM Rule 17.37D(1).

• No share options were outstanding, granted, exercised, lapsed or cancelled during the month. Accordingly, no new shares were issued and no funds were raised from option exercises.

• There were no outstanding warrants, convertible securities, or other share-issuance arrangements, and the filing indicated no other share movements.

Basetrophy GP’s unchanged capital metrics and confirmation of regulatory compliance underscore a steady capital structure through October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment